Can wearable sensors solve the mystery of heavy periods?
NCT ID NCT07557992
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
Heavy menstrual bleeding affects 1 in 3 women, yet there's no simple test to diagnose it. This study will use wearable sensors and MRI scans to measure uterine activity in 100 women with and without heavy periods. The goal is to identify biological differences that could lead to a future diagnostic tool.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this research could lead to a simple, accurate diagnostic test for heavy menstrual bleeding, improving diagnosis and treatment.
- What could go wrong
- This is an early observational study, not a treatment trial. It may not identify clear differences or lead to a usable test.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2026
- Expected to finish
-
Feb 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants will be recruited from in and around Hampshire with the ability to attend Southampton General Hospital for appointments. They will be recruited from both within hospital settings but also the community as many women suffer with HMB without seeking support.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 18-45 * Having Periods Exclusion Criteria: * Currently pregnant or breastfeeding. * Known uterine malignancy, severe anaemia requiring urgent treatment, or other acute gynaecological emergencies. * Inability to undergo MRI (e.g., pacemaker, severe claustrophobia). * Inability to provide informed consent. * Current use of hormonal treatment, or use in the last 2 months
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Menorrhagia due to benign causes are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University Hospital Southampton
RECRUITINGSouthampton, so16 6yd, United Kingdom